MR spectroscopy may be useful in glioblastoma treatment assessment

07/31/2013 |

Researchers at the Winship Cancer Institute of Emory University have been studying ways to assess drug treatment response in glioblastoma patients, and their efforts recently got a boost with a $4 million National Cancer Institute grant. The team has been using magnetic resonance spectroscopy to assess changes in tumor metabolism. "It lets us see something we otherwise couldn't see, something that can help us make best decisions for our patients. Glioblastoma is just an awful disease, and anything that can lighten the burden is tremendously important," said neurosurgeon Dr. Jeffrey Olson.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN